Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Eli Lilly
LLY
$1T
| $1T | $1,126.66 | 0.47% |
|
| 2 |
2
Johnson & Johnson
JNJ
$608B
| $608B | $252.33 | 0.82% |
|
| 3 |
3
AbbVie
ABBV
$429B
| $429B | $242.70 | 0.98% |
|
| 4 |
4
UnitedHealth
UNH
$371B
| $371B | $408.27 | 1.71% |
|
| 5 |
5
Merck
MRK
$318B
| $318B | $128.80 | 0.81% |
|
| 6 |
6
Novartis
NVS
$292B
| $292B | $153.74 | 0.05% |
|
| 7 |
7
AstraZeneca
AZN
$244B
| $244B | $157.43 | 0.34% |
|
| 8 |
NVO
8
Novo Nordisk
NVO
$210B
| $210B | $47.43 | 0.72% |
|
| 9 |
9
Thermo Fisher Scientific
TMO
$209B
| $209B | $565.50 | 1.49% |
|
| 10 |
10
Amgen
AMGN
$208B
| $208B | $385.53 | 1.76% |
|
| 11 |
11
Abbott
ABT
$183B
| $183B | $105.81 | 1.22% |
|
| 12 |
12
Gilead Sciences
GILD
$162B
| $162B | $130.61 | 0.41% |
|
| 13 |
13
Pfizer
PFE
$146B
| $146B | $25.55 | 2.08% |
|
| 14 |
14
Danaher
DHR
$138B
| $138B | $196.19 | 0.66% |
|
| 15 |
15
CVS Health
CVS
$133B
| $133B | $104.29 | 1.02% |
|
| 16 |
16
Bristol-Myers Squibb
BMY
$131B
| $131B | $64.33 | 1.74% |
|
| 17 |
17
Intuitive Surgical
ISRG
$129B
| $129B | $366.32 | 2.42% |
|
| 18 |
18
Stryker
SYK
$129B
| $129B | $335.44 | 1.69% |
|
| 19 |
19
Vertex Pharmaceuticals
VRTX
$122B
| $122B | $479.08 | 1.78% |
|
| 20 |
20
Medtronic
MDT
$110B
| $110B | $85.92 | 0.88% |
|
| 21 |
21
GSK
GSK
$103B
| $103B | $51.47 | 0.08% |
|
| 22 |
22
Sanofi
SNY
$103B
| $103B | $42.86 | 0.21% |
|
| 23 |
23
McKesson
MCK
$97.1B
| $97.1B | $829.56 | 0.29% |
|
| 24 |
24
HCA Healthcare
HCA
$86B
| $86B | $397.11 | 2.34% |
|
| 25 |
25
Elevance Health
ELV
$82.3B
| $82.3B | $379.64 | 0.82% |
|
Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.93T.
The largest by market cap are Eli Lilly (LLY) at $1T, Johnson & Johnson (JNJ) at $608B and AbbVie (ABBV) at $429B.
Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.
- Combined market cap: $8.93T across 1,066 stocks.
- Largest constituent: Eli Lilly (LLY), $1T market cap.
- Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.